Literature DB >> 8023842

Homozygous deletions on the short arm of chromosome 9 in ovarian adenocarcinoma cell lines and loss of heterozygosity in sporadic tumors.

G Chenevix-Trench1, J Kerr, M Friedlander, T Hurst, B Sanderson, M Coglan, B Ward, J Leary, S K Khoo.   

Abstract

Rat ovarian surface epithelial cells transformed spontaneously in vitro have been found to have homozygous deletions of the interferon alpha (IFNA) gene. This suggests that inactivation of a tumor-suppressor gene in this region may be crucial for the development of ovarian cancer. We therefore used microsatellite markers and Southern analysis to examine the homologous region in humans--the short arm of chromosome 9--for deletions in sporadic ovarian adenocarcinomas and ovarian tumor cell lines. Loss of heterozygosity occurred in 34 (37%) of 91 informative sporadic tumors, including some benign, low-malignant-potential and early-stage tumors, suggesting that it is an early event in the development of ovarian adenocarcinoma. Furthermore, homozygous deletions on 9p were found in 2 of 10 independent cell lines. Deletion mapping of the tumors and lines indicates that the candidate suppressor gene inactivated as a consequence lies between D9S171 and the IFNA locus, a region that is also deleted in several other tumors and that contains the melanoma predisposition gene, MLM.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8023842      PMCID: PMC1918224     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  45 in total

1.  A second-generation linkage map of the human genome.

Authors:  J Weissenbach; G Gyapay; C Dib; A Vignal; J Morissette; P Millasseau; G Vaysseix; M Lathrop
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

2.  Incessant ovulation--a factor in ovarian neoplasia?

Authors:  M F Fathalla
Journal:  Lancet       Date:  1971-07-17       Impact factor: 79.321

3.  Comparison of four new cell lines from patients with adenocarcinoma of the ovary.

Authors:  L K Woods; R T Morgan; L A Quinn; G E Moore; T U Semple; K E Stedman
Journal:  Cancer Res       Date:  1979-11       Impact factor: 12.701

4.  Genetic and physical map of the interferon region on chromosome 9p.

Authors:  J W Fountain; M Karayiorgou; D Taruscio; S L Graw; A J Buckler; D C Ward; N C Dracopoli; D E Housman
Journal:  Genomics       Date:  1992-09       Impact factor: 5.736

5.  Mapping of the shortest region of overlap of deletions of the short arm of chromosome 9 associated with human neoplasia.

Authors:  O I Olopade; S K Bohlander; H Pomykala; E Maltepe; E Van Melle; M M Le Beau; M O Diaz
Journal:  Genomics       Date:  1992-10       Impact factor: 5.736

6.  Early loss of heterozygosity on 17q in ovarian cancer. The Abe Ovarian Cancer Genetics Group.

Authors:  D M Eccles; S E Russell; N E Haites; R Atkinson; D W Bell; L Gruber; I Hickey; K Kelly; H Kitchener; R Leonard
Journal:  Oncogene       Date:  1992-10       Impact factor: 9.867

7.  A cell cycle regulator potentially involved in genesis of many tumor types.

Authors:  A Kamb; N A Gruis; J Weaver-Feldhaus; Q Liu; K Harshman; S V Tavtigian; E Stockert; R S Day; B E Johnson; M H Skolnick
Journal:  Science       Date:  1994-04-15       Impact factor: 47.728

8.  Deletion of chromosome 11p13-11p15.5 sequences in invasive human ovarian cancer is a subclonal progression factor.

Authors:  B Vandamme; W Lissens; K Amfo; P De Sutter; C Bourgain; E Vamos; J De Grève
Journal:  Cancer Res       Date:  1992-12-01       Impact factor: 12.701

9.  Homozygous deletions within human chromosome band 9p21 in melanoma.

Authors:  J W Fountain; M Karayiorgou; M S Ernstoff; J M Kirkwood; D R Vlock; L Titus-Ernstoff; B Bouchard; S Vijayasaradhi; A N Houghton; J Lahti
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

10.  Lack of expression of tumor-suppressor genes in human malignant glioma cell lines.

Authors:  R Godbout; J Miyakoshi; K D Dobler; R Andison; K Matsuo; M J Allalunis-Turner; H Takebe; R S Day
Journal:  Oncogene       Date:  1992-09       Impact factor: 9.867

View more
  8 in total

1.  ABCA transporter gene expression and poor outcome in epithelial ovarian cancer.

Authors:  Ellen L Hedditch; Bo Gao; Amanda J Russell; Yi Lu; Catherine Emmanuel; Jonathan Beesley; Sharon E Johnatty; Xiaoqing Chen; Paul Harnett; Joshy George; Rebekka T Williams; Claudia Flemming; Diether Lambrechts; Evelyn Despierre; Sandrina Lambrechts; Ignace Vergote; Beth Karlan; Jenny Lester; Sandra Orsulic; Christine Walsh; Peter Fasching; Matthias W Beckmann; Arif B Ekici; Alexander Hein; Keitaro Matsuo; Satoyo Hosono; Toru Nakanishi; Yasushi Yatabe; Tanja Pejovic; Yukie Bean; Florian Heitz; Philipp Harter; Andreas du Bois; Ira Schwaab; Estrid Hogdall; Susan K Kjaer; Allan Jensen; Claus Hogdall; Lene Lundvall; Svend Aage Engelholm; Bob Brown; James Flanagan; Michelle D Metcalf; Nadeem Siddiqui; Thomas Sellers; Brooke Fridley; Julie Cunningham; Joellen Schildkraut; Ed Iversen; Rachel P Weber; Andrew Berchuck; Ellen Goode; David D Bowtell; Georgia Chenevix-Trench; Anna deFazio; Murray D Norris; Stuart MacGregor; Michelle Haber; Michelle J Henderson
Journal:  J Natl Cancer Inst       Date:  2014-06-23       Impact factor: 13.506

Review 2.  Mutations in components of antiviral or microbial defense as a basis for breast cancer.

Authors:  Bernard Friedenson
Journal:  Funct Integr Genomics       Date:  2013-09-21       Impact factor: 3.674

Review 3.  The genetic analysis of ovarian cancer.

Authors:  A N Shelling; I E Cooke; T S Ganesan
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

4.  Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas.

Authors:  J Tapper; R Bützow; T Wahlström; M Seppälä; S Knuutila
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  CDKN2A gene inactivation in epithelial sporadic ovarian cancer.

Authors:  D Niederacher; H Y Yan; H X An; H G Bender; M W Beckmann
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

6.  High frequency of chromosome 9 deletion in ovarian cancer: evidence for three tumour-suppressor loci.

Authors:  J Devlin; P A Elder; H Gabra; C M Steel; M A Knowles
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

7.  Sporadic CDKN2 (MTS1/p16ink4) gene alterations in human ovarian tumours.

Authors:  M Schuyer; I L van Staveren; J G Klijn; M E vd Burg; G Stoter; S C Henzen-Logmans; J A Foekens; E M Berns
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

8.  Cytogenetic alterations in ovarian clear cell carcinoma detected by comparative genomic hybridisation.

Authors:  J Dent; G D Hall; N Wilkinson; T J Perren; I Richmond; A F Markham; H Murphy; S M Bell
Journal:  Br J Cancer       Date:  2003-05-19       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.